Trafigura Acquires Additional Shares in EMED

AIM: EMED 

TSX: EMD 26 August 2014

Trafigura Acquires Additional Shares in EMED

The Company has been notified that Trafigura Beheer B.V. ("Trafigura") has, through its wholly owned indirect subsidiary Urion Holdings (Malta) Limited ("Urion"), acquired 30,856,481 ordinary shares ("Ordinary Shares") of EMED effective 21 Aug 2014, pursuant to private transactions. The Ordinary Shares were purchased by Urion for a value of GBP 0.09 per Ordinary Share (approximately $0.1633 Cdn. per Ordinary Share). Trafigura now exercises control or direction over an aggregate of 259,029,997 Ordinary Shares, representing approximately 18.04% of the outstanding Ordinary Shares. Trafigura has stated that it has acquired the Ordinary Shares for investment purposes. Depending on market and other conditions, Trafigura may change its beneficial ownership of, or control or direction over, Ordinary Shares through market transactions, private agreements, treasury issuances or otherwise. Trafigura has no role in management of EMED and has not appointed any nominees to the Board of Directors of EMED.

Enquiries